Not checked for notices yet.
Design and optimisation of dendrimer-conjugated Bcl-2/xL inhibitor, AZD0466, with improved therapeutic index for cancer therapy
Claire M. Patterson, Srividya B. Balachander, Iain Grant and 28 more
Communications Biology · 2021
doi:10.1038/s42003-020-01631-8
Cited by papers we hold 3
- The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy · 2025No notice
- PEGylated therapeutics in the clinic · 2023No notice
- Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives · 2021No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.